NYSEMKT: ATNM
Actinium Pharmaceuticals Inc Stock Ownership - Who owns Actinium Pharmaceuticals?

Insider buying vs selling

Have Actinium Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Sandesh SethChief Executive Officer2025-08-18120,900$1.71
$206.74kSell

1 of 1

ATNM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATNM insiders and whales buy or sell their stock.

ATNM Shareholders

What type of owners hold Actinium Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Diane S. Button63.75%20,000,000$19.60MInsider
Sloan Kettering Cancer Center Memorial33.19%10,411,948$10.20MInsider
Vanguard Capital Management LLC4.00%1,255,516$1.23MInstitution
Acadian Asset Management LLC1.91%600,819$588.80kInstitution
Millennium Management LLC1.80%564,600$553.31kInstitution
Renaissance Technologies LLC1.50%471,600$462.17kInstitution
Blackrock Inc1.18%371,210$363.79kInstitution
Two Sigma Investments LP1.07%337,168$330.42kInstitution
Geode Capital Management LLC1.07%336,073$329.35kInstitution
Gagnon Securities LLC0.64%201,300$197.27kInstitution

1 of 3

ATNM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATNM14.66%85.34%Net Selling
LSTA1.19%98.81%Net Selling
SDEV1.52%98.48%
BOLD37.78%23.74%
RADX2.17%7.66%

Actinium Pharmaceuticals Stock Ownership FAQ

Who owns Actinium Pharmaceuticals?

Actinium Pharmaceuticals (NYSEMKT: ATNM) is owned by 16.90% institutional shareholders, 98.37% Actinium Pharmaceuticals insiders, and 0.00% retail investors. Diane S. Button is the largest individual Actinium Pharmaceuticals shareholder, owning 20.00M shares representing 63.75% of the company. Diane S. Button's Actinium Pharmaceuticals shares are currently valued at $20.40M.

If you're new to stock investing, here's how to buy Actinium Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.